• Five infectious diseases that might re-emerge

    Dreaded infectious diseases of the past have largely been kept at bay by antibioitcs and other medical advances; these diseases still linger, though, and could pose a threat – either because some parents refuse to vaccinate their kids owing to concerns about possible links between such vaccination and autism (Mumps), or because terrorist might use the pathogens in a bioterror attack (small pox)

  • Germ threat: Preparing for bioterrorism

    The Christmas terrorist near-miss serves as a reminder, if one were needed, that there are hundreds of terrorist planners, and thousands of dedicated followers, who plot day and night to inflict harm on the United States and its people; former Senators Bob Graham (D-Florida), and Jim Talent (R-Missouri), co-chairmen of the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism, argue that the most likely weapon of mass destruction terrorists will use would be biological weapons; the two also argue that the H1N1 flu crisis offered an early test of the U.S. abilities to respond to bioterrorism; they conclude the United States flunked it badly

  • Texas foundation wins contract to assist in fight against bioterrorism

    Southwest Foundation for Biomedical Research receives first installment of $456,216 of a $2.2 million contract to do research on Ebola and Marburg viruses, which could be used as potential bioterror weapons

  • NIH grants to aid study of smallpox and other bioterror-related diseases

    NIH gives the La Jolla Institute $18.8 million to do immunological research into diseases which could be used in bioterrorist attacks; the institute will study vaccines and treatments for smallpox, dengue, malaria, and tuberculosis

  • U.S. post Office to deliver antidote in case of anthrax attack

    President Obama signed an executive order instructing the Post Office to deliver antidotes to citizens in the event of an anthrax attack; the executive order calls for armed escorts to accompany delivery personnel

  • First case of highly drug-resistant TB found in U.S.

    The first case of extremely drug-resistant (XXDR) TB is found in the united States; one of the U.S. leading experts on tuberculosis says about the patient: “He is really the future….This is the new class that people are not really talking too much about. These are the ones we really fear because I’m not sure how we treat them”

  • Mystery solved: Scientists now know how smallpox kills

    New discovery fills a major gap in the scientific understanding of pox diseases and lays the foundation for the development of antiviral treatments, should smallpox or related viruses re-emerge through accident, viral evolution, or terrorist action

  • Obama administration to review U.S. response to health threats

    Health and Human Services Secretary Kathleen Sebelius said that she ordered the evaluation of the U.S. responses to health threats in part because the H1N1 vaccine shortage had highlighted the nation’s dependence on antiquated technology

  • Potent new biodefense technology shows promise

    Medizone International’s AsepticSure technology continues to break the “6 log” decontamination barriers, this time with two very different spore forming bacteria, Claustridium difficile and Bacillis subtilis

  • Experts call for changes in U.S. vaccine creation process

    The current U.S. vaccine-manufacturing plan was developed prior to the cold war, and has never been updated; currently, the United States grows its vaccines in eggs over the course of six to eight months, and as there has been no real financial incentive to upgrade the vaccine making process, pharmaceutical manufacturers have instead focused on more profitable medications rather than vaccines

  • Governments worry about more cases of drug-resistant H1N1

    Health officials in the United Kingdom and the United States report the likely person-to-person spread of a drug-resistant strain of H1N1; most patients thus far infected with the strain have already been immune-deficient

  • Bioterrorism poses new challenges for the health care systems worldwide

    A new book points out to one of the essential challenges bioterrorism poses: Nations’ primary health care system must be prepared properly to cope with cases of exceptional morbidity due to uncommon generators

  • Anticipating new diseases, bioterror methods

    The 150 researchers at the University of Florida’s Emerging Pathogens Institute work to anticipate and respond to new diseases and old ones — such as tuberculosis and cholera — that can turn into new threats or make a comeback

  • NIAID allocated $208 million to fight emerging infectious diseases from bioterrorism

    Using its own research funds, augmented by stimulus package money, NIH awarded $208 million to two programs that support research better to understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism

  • SRI opens Virginia facility

    SRI International opened a new facility for its Center for Advanced Drug Research (CADRE); scientists at the new facility will work on developing vaccines, more quickly diagnosing infections, and developing new treatments